Literature DB >> 11701250

How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis.

K L Brunson1, M Eghbal-Ahmadi, T Z Baram.   

Abstract

West syndrome (WS) is associated with diverse etiological factors. This fact has suggested that there must be a 'final common pathway' for these etiologies, which operates on the immature brain to result in WS only at the maturational state present during infancy. Any theory for the pathogenesis of WS has to account for the unique features of this disorder. For example, how can a single entity have so many etiologies? Why does WS arise only in infancy, even when a known insult had occurred prenatally, and why does it disappear? Why is WS associated with lasting cognitive dysfunction? And, importantly, why do these seizures--unlike most others--respond to treatment by a hormone, ACTH? The established hormonal role of ACTH in human physiology is to function in the neuroendocrine cascade of the responses to all stressful stimuli, including insults to the brain. As part of this function, ACTH is known to suppress the production of corticotropin releasing hormone (CRH), a peptide that is produced in response to diverse insults and stressors.The many etiologies of WS all lead to activation of the stress response, including increased production and secretion of the stress-neurohormone CRH. CRH has been shown, in infant animal models, to cause severe seizures and death of neurons in areas involved with learning and memory. These effects of CRH are restricted to the infancy period because the receptors for CRH, which mediate its action on neurons, are most abundant during this developmental period. ACTH administration is known to inhibit production and release of CRH via a negative feedback mechanism. Therefore, the efficacy of ACTH for WS may depend on its ability to decrease the levels of the seizure-promoting stress-neurohormone CRH.This CRH-excess theory for the pathophysiology of WS is consistent not only with the profile of ACTH effects, but also with the many different 'causes' of WS, with the abnormal ACTH levels in the cerebrospinal fluid of affected infants and with the spontaneous disappearance of the seizures. Furthermore, if CRH is responsible for the seizures, and CRH-mediated neuronal injury contributes to the worsened cognitive outcome of individuals with WS, then drugs which block the actions of CRH on its receptors may provide a better therapy for this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11701250      PMCID: PMC3107538          DOI: 10.1016/s0387-7604(01)00312-6

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  46 in total

1.  Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala.

Authors:  T Z Baram; E Hirsch; O C Snead; L Schultz
Journal:  Ann Neurol       Date:  1992-05       Impact factor: 10.422

2.  Considerations on the significance attributed to unusual cerebral histological findings recently described in eight patients with primary generalized epilepsy.

Authors:  G Lyon; H Gastaut
Journal:  Epilepsia       Date:  1985 Jul-Aug       Impact factor: 5.864

3.  Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress.

Authors:  T Imaki; J L Nahan; C Rivier; P E Sawchenko; W Vale
Journal:  J Neurosci       Date:  1991-03       Impact factor: 6.167

Review 4.  Infantile spasms.

Authors:  R A Hrachovy; J D Frost
Journal:  Pediatr Clin North Am       Date:  1989-04       Impact factor: 3.278

5.  Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol.

Authors:  O C Snead; J W Benton; L C Hosey; J W Swann; D Spink; D Martin; R Rej
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

6.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

7.  Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia.

Authors:  A Nalin; F Facchinetti; V Galli; F Petraglia; R Storchi; A R Genazzani
Journal:  Epilepsia       Date:  1985 Sep-Oct       Impact factor: 5.864

8.  Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms.

Authors:  T Z Baram; W G Mitchell; O C Snead; E J Horton; M Saito
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910

9.  Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue.

Authors:  H V Vinters; R S Fisher; M E Cornford; V Mah; D L Secor; M J De Rosa; Y G Comair; W J Peacock; W D Shields
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

10.  Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat.

Authors:  T Z Baram; L Schultz
Journal:  Brain Res Dev Brain Res       Date:  1991-07-16
View more
  22 in total

Review 1.  Models for infantile spasms: an arduous journey to the Holy Grail...

Authors:  Tallie Z Baram
Journal:  Ann Neurol       Date:  2007-02       Impact factor: 10.422

2.  Animal models of infantile spasms: is the Holy Grail finally in sight?

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

3.  Adrenocorticotropic hormone protects learning and memory function in epileptic Kcna1-null mice.

Authors:  Morris H Scantlebury; Kyoung-Chul Chun; Shun-Chieh Ma; Jong M Rho; Do Young Kim
Journal:  Neurosci Lett       Date:  2017-02-27       Impact factor: 3.046

4.  Pediatric epilepsy: Five new things.

Authors:  Kelly Knupp; Susan Koh; Kristen Park
Journal:  Neurol Clin Pract       Date:  2012-03

Review 5.  Novel animal models of pediatric epilepsy.

Authors:  Stéphane Auvin; Eduardo Pineda; Don Shin; Pierre Gressens; Andrey Mazarati
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

Review 6.  Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children.

Authors:  Amy Brooks-Kayal
Journal:  Epilepsia       Date:  2011-01       Impact factor: 5.864

7.  A model of symptomatic infantile spasms syndrome.

Authors:  Morris H Scantlebury; Aristea S Galanopoulou; Lenka Chudomelova; Emmanuel Raffo; David Betancourth; Solomon L Moshé
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

8.  Infantile spasms: a critical review of emerging animal models.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2009 May-Jun       Impact factor: 7.500

9.  Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females.

Authors:  Eric Marsh; Carl Fulp; Ernest Gomez; Ilya Nasrallah; Jeremy Minarcik; Jyotsna Sudi; Susan L Christian; Grazia Mancini; Patricia Labosky; William Dobyns; Amy Brooks-Kayal; Jeffrey A Golden
Journal:  Brain       Date:  2009-05-12       Impact factor: 13.501

10.  GABA(A) receptor properties in catastrophic infantile epilepsy.

Authors:  Laura A Jansen; Lindsey D Peugh; Jeffrey G Ojemann
Journal:  Epilepsy Res       Date:  2008-07-22       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.